³Ô¹ÏÍøÕ¾

Latest immunotherapy News | Page 2

Study points at novel approach to treat Group 3 medulloblastoma
New Strategy Can Improve Cell Therapy Against Cancer
Scientists exploring more targeted radiation for glioblastoma
Ellenbrook champion urging the community to donate to cancer research this Daffodil Day Appeal
Vaccines to treat human papillomavirus could be a significant innovation in the fight against cervical cancer
Ovarian Cancer Breakthrough: Tiny Protein, Big Impact
Defeating Lung Cancer
Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer
Many CLINTEC researchers recipients of CIMED project grants and clinical research months 2025-2027
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods
The rare condition that causes the body to produce its own alcohol
From immunotherapy to mRNA vaccines – the latest science on melanoma treatment explained
Immutep announces major capital raise and third collaboration with MSD
Two-pronged attack strategy boosts immunotherapy in preclinical studies
How Research In Common Cancers Is Helping Rare Cancers
We’re the ‘allergy capital of the world’. But we don’t know why food allergies are so common in Australian children
Research Funding For Ovarian Cancer Treatment
Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
Study opens the door to new treatment strategies for breast cancer
CAR T cell therapy for pediatric brain cancer warrants further study
“I’m still alive because of it”: Cancer survivor’s research request
Unlocking the body’s defences: understanding immunotherapy
AdAlta appoints Melbourne-based Cell Therapies as preferred manufacturing partner
A West Australian cancer researcher is running a half marathon this May to help raise vital funds
Advancing melanoma treatment against resistance
AI Predicts Tumor-killing Cells With High Accuracy
Personalised mRNA vaccines: a revolutionary new approach in melanoma treatment
Early Genetic Development Of Brain Mapped
La Trobe receives $11.5 million for vital health research
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within
Young melanoma survivor becomes face of new appeal for cancer support services
Tsetse fly protein provides anti-clotting agent with its own on-off switch
One-two punch treatment delivers blood cancer knockout
Immune cells lost in translation: Breakthrough into body’s response to blood cancer
Professor Mimi Tang Receives Distinguished Leadership Award
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Immutep appoints research institute to conduct first-in-human study of IMP761
World-class cancer research centre announced for QIMR Berghofer
Princess Alexandra Hospital home to world first cancer trial
What Are Types Of Cancer Treatments?
Ludwig Cancer Research Scientists to Present at AACR Annual Meeting
The Swedish Childhood Cancer Fund finances 8 research positions at KI
New Hope In Immunotherapy Against Cancer
Breakthroughs In Cancer Care With Professor Robyn Ward
Preparing For Allergic Reaction